Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker: TRexBio, Metsera & more
Welcome to Fierce Biotech's Fundraising Tracker, 2024's version.
Gabrielle Masson
,
Annalee Armstrong
,
Darren Incorvaia
,
Max Bayer
Nov 13, 2024 11:00am
Metsera follows phase 1 weight loss data with $215M series B
Nov 13, 2024 9:15am
Trace uses $101M series A to go after same ALS target as Lilly
Nov 12, 2024 7:00am
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio
Nov 7, 2024 11:35am
Radiopharma Alpha-9 raises $175M series C to fund clinical push
Oct 23, 2024 9:15am